U.S. flag

An official website of the United States government

NM_000543.5(SMPD1):c.1550A>T (p.Glu517Val) AND Sphingomyelin/cholesterol lipidosis

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Jan 22, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001249037.12

Allele description [Variation Report for NM_000543.5(SMPD1):c.1550A>T (p.Glu517Val)]

NM_000543.5(SMPD1):c.1550A>T (p.Glu517Val)

Gene:
SMPD1:sphingomyelin phosphodiesterase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p15.4
Genomic location:
Preferred name:
NM_000543.5(SMPD1):c.1550A>T (p.Glu517Val)
HGVS:
  • NC_000011.10:g.6394261A>T
  • NG_011780.1:g.8837A>T
  • NG_029615.1:g.30154T>A
  • NM_000543.5:c.1550A>TMANE SELECT
  • NM_001007593.3:c.1547A>T
  • NM_001318087.2:c.*43A>T
  • NM_001318088.2:c.629A>T
  • NM_001365135.2:c.1418A>T
  • NP_000534.3:p.Glu517Val
  • NP_001007594.2:p.Glu516Val
  • NP_001305017.1:p.Glu210Val
  • NP_001352064.1:p.Glu473Val
  • NC_000011.9:g.6415491A>T
  • NM_000543.4:c.1550A>T
  • NM_000543.5(SMPD1):c.1550A>TMANE SELECT
  • NR_027400.3:n.1503A>T
  • NR_134502.2:n.1042A>T
  • p.Glu517Val
Protein change:
E210V
Links:
dbSNP: rs142787001
NCBI 1000 Genomes Browser:
rs142787001
Molecular consequence:
  • NM_001318087.2:c.*43A>T - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_000543.5:c.1550A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001007593.3:c.1547A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001318088.2:c.629A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001365135.2:c.1418A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_027400.3:n.1503A>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_134502.2:n.1042A>T - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Sphingomyelin/cholesterol lipidosis
Synonyms:
Niemann-Pick disease
Identifiers:
MONDO: MONDO:0001982; MedGen: C0028064

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001422972Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Jan 22, 2020)
germlinecuration

PubMed (3)
[See all records that cite these PMIDs]

Citation Link,

SCV001452643Natera, Inc.
no assertion criteria provided
Uncertain significance
(May 4, 2017)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation

Citations

PubMed

Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency.

Wasserstein MP, Jones SA, Soran H, Diaz GA, Lippa N, Thurberg BL, Culm-Merdek K, Shamiyeh E, Inguilizian H, Cox GF, Puga AC.

Mol Genet Metab. 2015 Sep-Oct;116(1-2):88-97. doi: 10.1016/j.ymgme.2015.05.013. Epub 2015 May 30.

PubMed [citation]
PMID:
26049896
PMCID:
PMC4561589

Newborn screening for lysosomal storage disorders in hungary.

Wittmann J, Karg E, Turi S, Legnini E, Wittmann G, Giese AK, Lukas J, Gölnitz U, Klingenhäger M, Bodamer O, Mühl A, Rolfs A.

JIMD Rep. 2012;6:117-25. doi: 10.1007/8904_2012_130. Epub 2012 Mar 21.

PubMed [citation]
PMID:
23430949
PMCID:
PMC3565645
See all PubMed Citations (3)

Details of each submission

From Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard, SCV001422972.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (3)

Description

The p.Glu517Val variant in SMPD1 (also known as p.Glu515Val due to a difference in cDNA numbering) has been reported in at least 2 individuals with Niemann-Pick disease (PMID: 23430949, 26049896) and has been identified in 0.410% (529/129080) of European (non-Finnish) chromosomes, including 2 homozygotes, 0.192% (68/35430) of Latino chromosomes, and 0.108% (27/24970) of African chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs142787001). This variant has also been reported in ClinVar (VariationID: 198094) as likely benign by EGL Genetic Diagnostics and as a VUS by ARUP Laboratories and Integrated Genetics. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The presence of this variant in combination with a reported pathogenic variant and in an individual with Niemann-Pick disease increases the likelihood that the p.Glu517Val variant is pathogenic (VariationID: 2994; PMID: 23430949). In summary, the clinical significance of the p.Glu517Val variant is uncertain. ACMG/AMP Criteria applied: BS1, PP3, PM3_Supporting (Richards 2015).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Natera, Inc., SCV001452643.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024